Results 71 to 80 of about 16,181 (154)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction

Journal of Community Hospital Internal Medicine Perspectives, 2019
Hypothesis: In the care of acute myocardial infarction, ticagrelor attenuates post-ischemic myocardial damage and inhibits platelet activity to a greater extent than clopidogrel.
Candice Volney, Anthony Collins, Sarah Adams   +2 more
doaj   +1 more source

Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis

Drug Design, Development and Therapy, 2016
Michael R Preusch,1 Jonas Rusnak,1 Kathrin Staudacher,2 Carolin Mogler,3 Lorenz Uhlmann,4 Philipp Sievers,1 Florian Bea,1 Hugo A Katus,1 Erwin Blessing,1 Ingo Staudacher1 1Department of Internal Medicine III, 2Department of Neonatology, 3Department of ...
Preusch MR, Rusnak J, Staudacher K, Mogler C, Uhlmann L, Sievers P, Bea F, Katus HA, Blessing E, Staudacher I   +9 more
doaj  

Routine CYP2C19 Genotyping, Antiplatelet Prescription Changes, and Clinical Outcomes After PCI in Chinese Patients With Coronary Heart Disease: A Single-Center Retrospective Study. [PDF]

Cardiol Res Pract
Niu D, Zhang M, Guan H.
europepmc   +1 more source

Probabilistic Risk-Benefit Profile of Ticagrelor Monotherapy After Short Dual Antiplatelet Therapy: A Bayesian Analysis of the ULTIMATE-DAPT Trial. [PDF]

Clin Pharmacol Ther
Yang N, Xie X, Guo N, Li L, Deng N, Wang X, Yang L, Gao H.   +7 more
europepmc   +1 more source

Indobufen-based dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and network meta-analysis. [PDF]

J Int Med Res
Gopinath A, Heo J, Fatima A, Yerrajonna A, George H, Mohd R, Turjman T, Azuwike UB, Bien-Aimé DPC, Lefevre JAS, Rech L, Asfaw MD, Ekumbal JR, Dalil L, Khawar MMH.   +14 more
europepmc   +1 more source

Impact of antiplatelet therapy on erectile dysfunction following percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. [PDF]

Front Med (Lausanne)
Choi J, Lee CU, Park HW, Kim JH, Lee YS, Ahn JH, Koh JS, Kang MG, Kim W, Tantry US, Gurbel PA, Hwang JY, Jeong YH.   +12 more
europepmc   +1 more source

Pharmacogenetics-Guided De-Escalation of Dual Antiplatelet Therapy Based on CYP2C19 Testing in Patients After Acute Coronary Syndrome: Clinical Outcomes and Cost-Consequence Analysis. [PDF]

J Clin Med
Turaev FK, Abdullaev SP, Matrenin KI, Gafurov FS, Tuchkova SN, Gabrielyan DA, Mirzaev KB, Kaprin DA, Sychev DA.   +8 more
europepmc   +1 more source

Prasugrel 5 mg in acute coronary syndromes: indications and clinical outcomes. [PDF]

Rev Assoc Med Bras (1992)
Tanajura LFL, Delamain JH, Labrunie A, Souza GBN, Tanajura LGO.   +4 more
europepmc   +1 more source

Ticagrelor is associated with periodic breathing during exercise in coronary patients undergoing cardiac rehabilitation: a retrospective observational study. [PDF]

Sleep Breath
Pointel S, Delavenne X, Bonjean P, Mismetti V, Vergnon JM, Froudarakis M, Hupin D, Isaaz K, Roche F.   +8 more
europepmc   +1 more source

Clopidogrel Versus Prasugrel Versus Ticagrelor in Patients with Acute Coronary Syndrome: New Insights from a Large Registry Compared to Randomized Clinical Trials-A Structured Review. [PDF]

J Clin Med
Umińska J, Białoszyński T, Skrzypek M, Gąsior M, Adamski P, Gajda R, Gurbel PA, Grzelakowska K, Dominiak T, Hudzik B, Kędziora-Kornatowska K, Tantry U, Specchia G, Szarpak Ł, Trzeciak P, Navarese EP.   +15 more
europepmc   +1 more source